MindMed is a psychedelic medicine biotech company that studies how shrooms, LSD, and even MDMA and DMT can help treat depression. Honestly, I already confirmed their studies to be …

2023年4月7日 · While I mostly agree with this (not the condescending part), this should end up positive and massive. Most of the people in this reddit stream have used the real thing at some …

2021年1月1日 · MindMed (MMED.F) was mentioned a ton of times a few weeks ago and pumped all the way to $6 a share (from <$1 a few months ag). Then they announced they were raising …

Over the past month, while FCM has provided MindMed’s Management (“Management”) with a comprehensive understanding of FCM’s Value Enhancement Plan (see mindmed.zone/letter), …

2021年2月16日 · MindMed maintains approximately $144.7M in cash on hand. 10. MindMed has at least five known catalysts expected to occur this year, including a Nasdaq listing that is …

MindMed results were extremely positive - 50% remission in a large Phase 2b trial. Now moving to Phase 3 with more solid data to support the company's proposal to the FDA. Where are the …

2022年3月11日 · August 4 2022 - mindmed board of directors approves 15:1 reverse split In conclusion, my read of the landscape here is that mindmed is in dire straits in terms of drug …

Mindmed was trading so high because it was being pumped on Wall Street bets and was doing an uplisting at the time. I had 1000 shares @ .78 and sold them for 6.25 with the plan to reinvest …

2021年1月13日 · #1 - MindMed has not filed form 40-F with the SEC. The Form 40-F is an annual form required for all companies trading on the Nasdaq. Any company that has been trading …

MindMed is waiting for approval of a Nasdaq uplisting, which I assume will impact value. I’ve already made good money off of this, and they’re just getting started. Please do dig in further …